PALB2 Genetic Variants: Can Functional Assays Assist Translation?

Melissa C Southey1, Amanda Rewse2, Tu Nguyen-Dumont3

  • 1Precision Medicine, School of Clinical Science at Monash Health, Monash University Clayton, VIC 3168, Australia; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC 3010, Australia; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia.

Trends in Cancer
|March 27, 2020
PubMed

Insights

Missense variants (MVs) in PALB2 can disrupt its function, increasing cancer risk. This research clarifies the clinical relevance of these PALB2 MVs, aiding family management and treatment decisions.

Area of Science:

  • Genetics and Oncology
  • Molecular Biology

Background:

  • Loss-of-function variants in the PALB2 gene are linked to elevated risks of breast and other cancers.
  • The clinical significance of PALB2 missense variants (MVs) is not well understood, creating uncertainty in patient care.

Purpose of the Study:

  • To investigate the functional impact of specific PALB2 missense variants.
  • To clarify the clinical relevance of PALB2 MVs for cancer risk assessment and patient management.

Main Methods:

  • Functional assays were used to assess the impact of MVs on PALB2 protein function.
  • Literature review of recent studies (Wiltshire et al., Rodrigue et al., Boonen et al.) was conducted.

Main Results:

  • Recent studies demonstrate that certain PALB2 MVs impair the protein's function.
  • This functional disruption by MVs contributes to the increased cancer risk associated with these variants.

Conclusions:

  • The functional characterization of PALB2 MVs provides crucial information for clinical decision-making.
  • Understanding the impact of these variants supports personalized management strategies for families carrying them.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...